Status:
COMPLETED
Grey Zone Appendicitis: Role of Blood Test Biomarkers to Detect Early Appendicitis and to Decrease the Incidence of Negative Appendectomy
Lead Sponsor:
Zagazig University
Conditions:
Appendicitis
Eligibility:
All Genders
14-80 years
Phase:
NA
Brief Summary
Introduction: many investigations emerged in the last decades and contribute towards a diagnosis of unsure appendicitis; they are valuable to the emergency general surgeon. Aim: This study aims to as...
Detailed Description
INTRODUCTION Acute appendicitis is a very common surgical emergency worldwide, with a lifetime risk reported to be 7-8%..Accordingly, appendectomy is the most frequently performed operation worldwide....
Eligibility Criteria
Inclusion
- Age: more than 14years of both sexes.
- Non pregnant female.
- Patients taking analgesics. .Patients who diagnosed to have grey zone diagnosis of acute appendicitis (Alvarado score 5-6).
Exclusion
- Alvarado score \>6 or \< 5.
- Cases of sure acute appendicitis.
- Documented Liver disease, biliary disease (congenital or acquired), hemolytic diseases and history of alcoholism.
- 4\) Cases revealed other pathology than appendicitis by CT and laparoscopy.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04271826
Start Date
August 1 2018
End Date
August 1 2019
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tamer Alsaied Alnaimy
Zagazig, Sharqia Province, Egypt, 1234